NervGen Pharma Corp. (NGENF)
OTCMKTS · Delayed Price · Currency is USD
2.725
+0.145 (5.62%)
Jul 9, 2025, 4:00 PM EDT

NervGen Pharma Market Cap

NervGen Pharma has a market cap or net worth of $197.19 million as of July 10, 2025. Its market cap has increased by 58.98% in one year.

Market Cap
197.19M
Enterprise Value
186.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.73

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y13 Jul 20209 Jul 2025Range ▾Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '250100M200M300M197M

Since March 15, 2019, NervGen Pharma's market cap has increased from 37.55M to 197.19M, an increase of 425.17%. That is a compound annual growth rate of 29.99%.

History

DateMarket Cap% Change
Jul 9, 2025197.19M28.52%
Dec 31, 2024153.43M25.91%
Dec 29, 2023121.86M75.67%
Dec 30, 202269.37M-29.11%
Dec 31, 202197.86M59.23%
Dec 31, 202061.46M38.56%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Endo, Inc. 1.62B
Veradigm 840.66M
Nika Pharmaceuticals 708.22M
Elite Pharmaceuticals 661.21M
Tian'an Technology Group 628.15M
Glass House Brands 536.01M
American Oncology Network 433.75M
CytoDyn 398.52M
Market Cap Rankings